Dr. Öğr. Üyesi MERVE ALAYLIOĞLU

Yayın Ağı

Makaleler 37

1. The CSF Levels of Mitochondrial Phosphoenolpyruvate Carboxykinase 2 as a Novel Biomarker in Alzheimer’s Disease

İlhan N., Şahin E., Ildız S., Samancı B., Sordu P., Alaylıoğlu M., et al.

Molecular Neurobiology , cilt.63, sa.1, 2026 (SCI-Expanded, Scopus)

2. Increased plasma soluble TREM2 levels in non-Alzheimer’s dementia

Güven G., Gezegen H., ŞAHİN E., Samancı B., Hanağası H., Gürvit H., et al.

Acta Neurologica Belgica , 2026 (SCI-Expanded, Scopus)

3. Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis

Gezegen H., ALAYLIOĞLU M., Şahin E., Swann O., Veleva E., Güven G., et al.

Alzheimer's and Dementia , cilt.21, sa.7, 2025 (SCI-Expanded, Scopus)

4. Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia.

Sordu P., Alaylıoğlu M., Samancı B., Bulu E., Güleç Z. E. K., Bilgiç B., et al.

Journal of Alzheimer's disease : JAD , cilt.105, ss.481-493, 2025 (SCI-Expanded, Scopus)

5. Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease

Ayaz G., SORDU DELİBALTA P., KÜÇÜKSEZER U. C., HANAĞASI H. A., ALAYLIOĞLU M., GÜRVİT İ. H., et al.

JOURNAL OF ALZHEIMERS DISEASE , cilt.105, sa.1, ss.172-185, 2025 (SCI-Expanded, Scopus)

6. Serum and Saliva Biomolecules in Periodontitis Patients with and without Alzheimer's Disease

ÖZTÜRK D., MİDİ İ., ALAYLIOĞLU M., Tuncer E., GEZEN AK D., DURSUN E., et al.

Nigerian Journal of Clinical Practice , cilt.28, sa.3, ss.409-416, 2025 (SCI-Expanded, Scopus)

7. A Novel and Robust Protocol for Differentiation of SH-SY5Y Neuroblastoma Cells into Neuron Like Cells

ALAYLIOĞLU M., Keskin E., Şengül Yediel B., DURSUN E., GEZEN AK D.

Noropsikiyatri Arsivi , cilt.61, sa.3, ss.255-264, 2024 (SCI-Expanded, Scopus, TRDizin)

8. The relations of circulating agouti-related peptide and leptin with altered sleep architecture in patients with active Cushing's disease: a pilot study

Sulu C., Senel G., Koca O., Alaylioglu M., Demir A. N., Durcan E., et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.47, sa.1, ss.167-178, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Biallelic frameshift variants in PHLDB1 cause mild-type osteogenesis imperfecta with regressive spondylometaphyseal changes.

TÜYSÜZ B., Uludag Alkaya D., GEYİK F., Alaylloǧlu M., Kasap B., KURUĞOĞLU S., et al.

Journal of medical genetics , cilt.60, sa.8, ss.819-826, 2023 (SCI-Expanded, Scopus)

10. Vitamin D receptor regulates transcription of mitochondrial DNA and directly interacts with mitochondrial DNA and TFAM

Gezen-Ak D., Alaylıoğlu M., Yurttaş Z., Çamoğlu T., Şengül B., İşler C., et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY , cilt.116, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry

Karras S. N., DURSUN E., ALAYLIOĞLU M., GEZEN AK D., Pilz S., Annweiler C., et al.

NUTRIENTS , cilt.14, sa.18, 2022 (SCI-Expanded, Scopus)

12. mir210 and BCL2 Expressions in Patients with Acute Myeloid Leukemia

Göktan H., Kuru R. D., Yılmaz Ş., Alaylıoğlu M., Dursun E., Ak D., et al.

BEZMIALEM SCIENCE , sa.4, ss.453-460, 2022 (ESCI)

13. **Genetic variants of vitamin D metabolism-related DHCR7/NADSYN1 locus and CYP2R1 gene are associated with clinical features of Parkinson's disease.**

Alaylioglu M., Dursun E., Genc G., Sengul B., BİLGİÇ B., Gunduz A., et al.

The International journal of neuroscience , cilt.132, sa.5, ss.439-449, 2022 (SCI-Expanded, Scopus)

14. Vitamin D mitigates atherosclerosis risk in TNF-alpha-induced endothelial cells

Onal B., Alaylioglu M., DURSUN E., GEZEN AK D.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , cilt.21, sa.4, ss.701-706, 2022 (SCI-Expanded, Scopus)

15. Upregulation of Irisin and Vitamin D-Binding Protein Concentrations by Increasing Maternal 25-Hydrovitamin D Concentrations in Combination with Specific Genotypes of Vitamin D-Binding Protein Polymorphisms

Karras S. N., DURSUN E., ALAYLIOĞLU M., GEZEN AK D., Al Anouti F., Pilz S., et al.

NUTRIENTS , cilt.14, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Pleiotropic effects of pitavastatin: a pilot study using the saphenous vein endothelial cell model of endothelial injury and prevention of atherosclerosis

Onal B., Alaylioglu M., Yenmis G., Dogan A. S., Dursun E., Gezen-Ak D., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.26, sa.14, ss.5210-5217, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis

Durmus H., Cakar A., Demirci H., ALAYLIOĞLU M., GEZEN AK D., DURSUN E., et al.

ACTA NEUROLOGICA SCANDINAVICA , cilt.144, sa.6, ss.640-646, 2021 (SCI-Expanded, Scopus)

18. Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1

Gönen M. S., Alaylıoğlu M., Durcan E., Özdemir Y., Şahin S., Konukoğlu D., et al.

NUTRIENTS , sa.11, 2021 (SCI-Expanded, Scopus)

19. Investigating the Role of Functional Polymorphism of Maternal and Neonatal Vitamin D Binding Protein in the Context of 25-Hydroxyvitamin D Cutoffs as Determinants of Maternal-Neonatal Vitamin D Status Profiles in a Sunny Mediterranean Region

Karras S. N., DURSUN E., Alayliohlu M., GEZEN AK D., Annweiler C., Al Anouti F., et al.

NUTRIENTS , cilt.13, sa.9, 2021 (SCI-Expanded, Scopus)

20. Protein disulfide isomerase A3 might be involved in the regulation of 24-dehydrocholesterol reductase via vitamin D equilibrium in primary cortical neurons

YAVUZ U., ALAYLIOĞLU M., Sengul B., Karras S. N., GEZEN AK D., DURSUN E.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL , cilt.57, ss.704-714, 2021 (SCI-Expanded, Scopus)

21. TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features

Samanci B., Bilgic B., Gelisin O., Tepgec F., Guven G., Tufekcioglu Z., et al.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.28, ss.2603-2613, 2021 (SCI-Expanded, Scopus)

22. Low Levels ofLRRK2Gene Expression are Associated withLRRK2SNPs and Contribute to Parkinson's Disease Progression

Yilmazer S., Candas E., Genc G., Alaylioglu M., Sengul B., GÜNDÜZ A., et al.

NEUROMOLECULAR MEDICINE , cilt.23, sa.2, ss.292-304, 2021 (SCI-Expanded, Scopus)

23. Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy

Karras S. N., Dursun E., Alaylıoğlu M., Gezen-Ak D., Annweiler C., Skoutas D., et al.

NUTRIENTS , cilt.13, sa.2, 2021 (SCI-Expanded, Scopus)

24. Gene expression profiling of primary fibrochondrocyte cultures in traumatic and degenerative meniscus lesions

Aydın N., Karaismailoğlu B., Alaylıoğlu M., Gezen-Ak D., Şengül B., Candaş E., et al.

JOURNAL OF ORTHOPAEDIC SURGERY , cilt.29, sa.1, 2021 (SCI-Expanded, Scopus)

25. A Bridge Between in vitro and in vivo Studies in Neuroscience: Organotypic Brain Slice Cultures

AlaylioĞlu M., Dursun E., Yilmazer S., Ak D.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.57, sa.4, ss.333-337, 2020 (SCI-Expanded, Scopus, TRDizin)

26. Vitamin D receptor Fokl polymorphism is a determinant of both maternal and neonatal vitamin D concentrations at birth.

Karras S. N., Koufakis T., Antonopoulou V., Goulis D. G., Alaylioglu M., DURSUN E., et al.

The Journal of steroid biochemistry and molecular biology , cilt.199, ss.105568, 2020 (SCI-Expanded, Scopus)

27. Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease

Gezen-Ak D., Alaylıoğlu M., Genç G., Şengül B., Keskin E., Sordu P., et al.

JOURNAL OF ALZHEIMERS DISEASE , sa.1, ss.287-307, 2020 (SCI-Expanded, Scopus)

28. Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1-42 IVD Kits.

Dursun E., Alaylioglu M., Bilgic B., Hanagasi H., Guervit H., Emre M., et al.

Journal of molecular neuroscience : MN , cilt.67, sa.4, ss.534-539, 2019 (SCI-Expanded, Scopus)

29. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.

ATAÇ Z., Alaylıoğlu M., Dursun E., Gezen-Ak D., YıLMAZER S., GÜRVIT H.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia , cilt.59, ss.197-201, 2019 (SCI-Expanded, Scopus)

30. The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.

Gezen-Ak D., ATASOY İ., CANDAŞ E., Alaylıoğlu M., Dursun E.

Neuromolecular medicine , cilt.20, ss.363-375, 2018 (SCI-Expanded, Scopus)

31. Vitamin D Receptor Regulates Amyloid Beta 1-42 Production with Protein Disulfide Isomerase A3.

Gezen-Ak D., Atasoy I. L., Candas E., Alaylioglu M., Yilmazer S., Dursun E.

ACS chemical neuroscience , cilt.8, sa.10, ss.2335-2346, 2017 (SCI-Expanded, Scopus)

32. GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features.

Gezen-Ak D., Alaylioglu M., GENC G., Gunduz A., Candas E., Bilgic B., et al.

Neuromolecular medicine , cilt.19, sa.1, ss.24-40, 2017 (SCI-Expanded, Scopus)

33. Erratum to: GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features.

Gezen-Ak D., Alaylıoğlu M., Genç G., Gündüz A., Candaş E., Bilgiç B., et al.

Neuromolecular medicine , cilt.19, ss.175-180, 2017 (SCI-Expanded, Scopus)

34. Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.

Dursun E., Alaylioglu M., Bilgic B., Hanagasi H., Lohmann E., Atasoy I. L., et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology , cilt.37, sa.10, ss.1633-43, 2016 (SCI-Expanded, Scopus)

35. The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.

Alaylioglu M., Gezen-Ak D., Dursun E., Bilgic B., Hanagasi H., Ertan T., et al.

Journal of geriatric psychiatry and neurology , cilt.29, sa.4, ss.221-6, 2016 (SCI-Expanded, Scopus)

36. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.

Dursun E., Gezen-Ak D., Hanagasi H., Bilgic B., Lohmann E., Ertan S., et al.

Journal of neuroimmunology , cilt.283, ss.50-7, 2015 (SCI-Expanded, Scopus)

37. BDNF, TNF alpha, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment

Gezen-Ak D., Dursun E., Hanagasi H., Bilgic B., Lohman E., Araz O. S., et al.

JOURNAL OF ALZHEIMERS DISEASE , cilt.37, sa.1, ss.185-195, 2013 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. In silico analysis of PSEN1 and PSEN2 missense SNPs in early-onset Alzheimer's disease

Acik F., ALAYLIOĞLU M.

58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan, İtalya, 24 - 27 Mayıs 2025, cilt.33, ss.298, (Özet Bildiri)

2. Clinical and Molecular Landscape of Amyotrophic Lateral Sclerosis Patients with OPTN Variants from Turkey and Possible Therapeutic Response to Inhibation of RIPK1

DURMUŞ TEKÇE H., ERZURUMLUOĞLU GÖKALP E., Gezenak D., Dursun E., Alaylioglu M., ÇAKAR A., et al.

Annual Meeting of the American-Academy-of-Neurology (AAN), California, Amerika Birleşik Devletleri, 5 - 09 Nisan 2025, cilt.104, (Özet Bildiri)

3. Reduced cerebrospinal fluid levels of the PCK2 protein in patients with Alzheimer's disease

Ilhan N., Ildiz S., Sahin E., SORDU DELİBALTA P., SAMANCI B., ALAYLIOĞLU M., et al.

57th Conference of the European-Society-of-Human-Genetics (ESHG), Berlin, Almanya, 1 - 04 Haziran 2024, cilt.32, ss.1502-1503, (Özet Bildiri)

4. Alzheimer Hastalığında mir24-3p ve mir26-5p Ekspresyon Düzeylerinin Endotel ve Trombosit Fonksiyonları Üzerine olan Etkisinin İncelenmesi

Ayaz G., Sordu P., Alaylıoğlu M., Samancı B., Bilgiç B., Hanağası H. A., et al.

XVIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Türkiye, 28 - 31 Ekim 2021, cilt.52, ss.78-79, (Özet Bildiri)

5. ‘’Investigation of the Molecular Mechanism of Endothelial Dysfunction and ADP-Induced Platelet Aggregation in Alzheimer's Disease’’

Ayaz G., Sordu P., Alaylıoğlu M., Samancı B., Bilgiç B., Hanağası H. A., et al.

8th International Congress of Molecular Medicine , İstanbul, Türkiye, 9 - 12 Kasım 2021, ss.15, (Özet Bildiri)

6. Cognitive involvement in ATTR amyloidosis (TTR-FAP)

DURMUŞ TEKÇE H., ÇAKAR A., Demirci H., Alaylioglu M., GEZEN AK D., DURSUN E., et al.

Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, 01 Ocak 2020, cilt.25, ss.527, (Özet Bildiri)

Kitaplar 3

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

633

H-İndeks (WoS)

Atıf (Scopus)

699

H-İndeks (Scopus)

Atıf (Scholar)

923

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler